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Introduction / objectives
Recent findings suggest that the Surgical Care Improve-
ment Project (SCIP) a US-Based “process initiative” fails
to reduce the risk of SSIs. The following evidence-based
discussion proposes a SCIP-PLUS perspective for redu-
cing risk of SSIs through enhanced antimicrobial pro-
phylaxis and embracing innovative antimicrobial risk
reduction technology.
Methods
Four risk reduction initiatives were studied, A: Impact of
BMI on antimicrobial prophylactic dosing in general,
OB and CT surgical patients; B: Development of stan-
dardized regimen of CHG preadmission cleansing to
improve outcome in surgical patients; C: Efficacy of
antimicrobial sutures to reduce the risk of suture con-
tamination at wound closure and D: The impact of an
innovative antimicrobial surgical glove to reduce the
risk of microbial contamination following glove
microperforation.
Results
A: 2-gm dosing in surgical patients failed to provide
adequate tissue concentrations at BMI >30 (p<0.05); B:
Standardization of skin cleansing using a 2% CHG
polyester cloths was effective at providing skin concen-
trations sufficient to inhibit/kill wound pathogens com-
pared to non-standardized regimen (p<0.001); C:
Laboratory/clinical studies demonstrate that antimicro-
bial suture technology is effective (p<0.05)a tr e d u c i n g
the risk of suture contamination and SSI; D: Innovative
antimicrobial surgical glove was effective (p<0.001)a t
reducing bacterial passage following microperforation
which can lead to wound contamination.
Conclusion
An effective SCIP-PLUS strategy requires multi-faceted
evidence-based approach including antimicrobial dosing
to compensate for BMI, thoughtful preadmission skin
cleansing, use of antimicrobial suture technology at
wound closure and embracing innovative antimicrobial
surgical glove technology reducing the risk of bacterial
passage into the surgical wound.
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